COVID-19 trials registries data warehouse

http://www.chictr.org.cn/showproj.aspx?proj=49947

Yu Hongzhi

ykb@tju.edu.cn

2020-02-24

Recruiting

RCT

Randomized

Factorial

Not reported

single-center

Treatment

(1) Confirmed patients (or legal guardian) sign a written informed consent form, (2) Aged from 18 to 80 years, male or female, (3) Patients with positive detection of 2019 Novel Coronavirus Pneumonia fluorescence RT-PCR in respiratory specimens or blood samples, (4) Mild ill, severe ill and critical ill patients are grouped based on the fifth edition of the treatment and diagnosis plan published by the National Health Commission of the Peoples Republic of China.

1) Patients who may be transferred to other hospitals that are not included in the trial within 72 hours, 2) G-6PD defect (Favism), 3) Pregnancy, especially early pregnancy, 4) Patients who continually use immunosuppressant, or are organ transplant recipients within 6 months, 5) Hyperthyroidism, 6) Patients with medical ozone allergy, 7) Patients who are receiving other clinical trials.

2

Tianjin University

18

80

China

No restriction on type of patients

0: No restriction on type of patients

60

Chest CT;Whole blood cell analysis;Recovery rate;Oxygenation index;Inflammatory response index;

| Declared number of arm (3.0) differs from found arms (4.0)

Phase 0

[{"arm_notes": "", "treatment_id": 951, "treatment_name": "Ozonated autohemotherapy", "treatment_type": "Life support", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]